1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Macias, M.J.
Gervais, V.
Civera, C.
Oschkinat, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
7
375
10.1038/75144
10802733
Structural Analysis of Ww Domains and Design of a Ww Prototype
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
3256.645
HYPOTHETICAL PROTEIN
DOMAIN
1
man
polymer
no
no
PGWEIIHENGRPLYYNAEQKTKLHYPP
PGWEIIHENGRPLYYNAEQKTKLHYPP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
4932
SACCHAROMYCES CEREVISIAE
562
ESCHERICHIA COLI
repository
Initial release
Version format compliance
Version format compliance
1
0
2000-06-02
1
1
2011-05-08
1
2
2011-07-13
PROTOTYPE WW DOMAIN
FBP28WW DOMAIN FROM MUS MUSCULUS
NMR RESTRAINTS FOR ENTRY 1E0N
PDBE
Y
PDBE
2000-04-01
REL
THE STRUCTURE WAS DETERMINED USING HOMONUCLEAR NMR
LOWEST ENERGY
20
10
NOESY
TOCSY
6.5
pH
285
K
simulated annealing
1
1. NILGES, M.
refinement
ARIA/CNS
structure solution
XEASY/ARIA/CNS
600
Bruker
DRX
PRO
7
n
1
PRO
7
A
GLY
8
n
2
GLY
8
A
TRP
9
n
3
TRP
9
A
GLU
10
n
4
GLU
10
A
ILE
11
n
5
ILE
11
A
ILE
12
n
6
ILE
12
A
HIS
13
n
7
HIS
13
A
GLU
14
n
8
GLU
14
A
ASN
15
n
9
ASN
15
A
GLY
16
n
10
GLY
16
A
ARG
17
n
11
ARG
17
A
PRO
18
n
12
PRO
18
A
LEU
19
n
13
LEU
19
A
TYR
20
n
14
TYR
20
A
TYR
21
n
15
TYR
21
A
ASN
22
n
16
ASN
22
A
ALA
23
n
17
ALA
23
A
GLU
24
n
18
GLU
24
A
GLN
25
n
19
GLN
25
A
LYS
26
n
20
LYS
26
A
THR
27
n
21
THR
27
A
LYS
28
n
22
LYS
28
A
LEU
29
n
23
LEU
29
A
HIS
30
n
24
HIS
30
A
TYR
31
n
25
TYR
31
A
PRO
32
n
26
PRO
32
A
PRO
33
n
27
PRO
33
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
12
A
N
ILE
6
A
O
LEU
19
A
O
LEU
13
A
N
ASN
22
A
N
ASN
16
A
O
THR
27
A
O
THR
21
1
A
GLU
10
-142.28
-152.40
1
A
GLU
14
-96.67
-68.03
1
A
ASN
22
-172.36
119.45
1
A
LEU
29
-177.66
-173.94
2
A
GLU
10
-138.20
-157.62
2
A
ASN
15
-164.80
-4.76
2
A
ASN
22
-175.34
123.75
3
A
GLU
10
-135.04
-157.08
3
A
ASN
15
-155.92
3.18
3
A
PRO
18
-62.12
90.85
3
A
LEU
29
176.57
-176.43
3
A
TYR
31
-171.02
147.32
4
A
GLU
10
-153.35
-156.09
4
A
ASN
15
-155.86
7.75
4
A
ASN
22
-172.08
130.40
4
A
LYS
26
75.88
82.50
4
A
PRO
32
-47.91
166.73
5
A
ASN
15
-156.54
-51.42
5
A
PRO
18
-32.20
138.65
5
A
ASN
22
-173.51
119.40
5
A
PRO
32
-49.13
168.90
6
A
GLU
10
-145.84
-155.84
6
A
ILE
12
-136.44
-156.40
6
A
ASN
15
-165.98
27.46
6
A
ASN
22
-172.78
124.28
7
A
GLU
10
-136.35
-154.38
7
A
PRO
18
-63.94
96.32
7
A
ASN
22
-177.36
120.01
7
A
LEU
29
178.37
-170.40
7
A
HIS
30
-126.54
-51.57
8
A
GLU
10
-137.82
-159.45
8
A
ASN
15
-166.36
-11.66
8
A
PRO
18
-65.18
90.31
8
A
ASN
22
-172.58
126.64
8
A
LYS
26
59.80
71.31
8
A
LEU
29
-175.86
-171.99
9
A
GLU
10
-138.06
-159.71
9
A
GLU
14
-123.55
-57.11
9
A
PRO
18
-66.83
93.98
9
A
ASN
22
-175.25
120.52
9
A
LEU
29
-178.78
-167.79
9
A
HIS
30
-133.04
-50.86
10
A
GLU
10
-134.95
-152.55
10
A
ASN
15
-165.42
7.60
10
A
PRO
18
-66.01
98.56
10
A
ASN
22
-175.17
120.62
10
A
LEU
29
179.26
171.12
HYPOTHETICAL PROTEIN
YJQ8WW domain from Saccharomyces cerevisae
1
N
N
YJQ8WW DOMAIN
YJQ8WW DOMAIN, WW DOMAIN, SACCHAROMYCES CEREVISAE, YJQ8 PROTEIN
A
PRO
32
A
PRO
26
7
A
PRO
33
A
PRO
27
1.86
A
TYR
31
A
TYR
25
9
A
PRO
32
A
PRO
26
-1.85
A
TYR
31
A
TYR
25
10
A
PRO
32
A
PRO
26
-3.11
1E0N
PDB
1
1E0N
7
33
1E0N
7
33
1E0N
A
1
1
27
3
anti-parallel
anti-parallel
A
TRP
9
A
TRP
3
A
GLU
14
A
GLU
8
A
ARG
17
A
ARG
11
A
ALA
23
A
ALA
17
A
LYS
26
A
LYS
20
A
HIS
30
A
HIS
24
1
P 1